Achieve Life Sciences prices $45M offering: 15M shares and warrants at $3.00 per unit

ACHIEVE LIFE SCIENCES, INC.

Public offering of 15M shares of common stock and accompanying warrants to purchase up to 15M shares, priced at $3.00 per unit.
Gross proceeds ~$45M; net proceeds ~$41.3M after underwriting discounts and expenses; expected close June 30, 2025.
Underwriters granted 30-day option to purchase up to an additional 2.25M shares and/or warrants.
Each warrant exercisable for one share at $3.00, or exchangeable for pre-funded warrant at $0.001/share; 5-year term; 9.99% ownership cap.
Proceeds to fund cytisinicline advancement for smoking cessation through potential FDA approval and for working capital.

item 1.01item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.